BRPI1009824A2 - dispersão sólida e forma farmacêutica sólida. - Google Patents
dispersão sólida e forma farmacêutica sólida.Info
- Publication number
- BRPI1009824A2 BRPI1009824A2 BRPI1009824A BRPI1009824A BRPI1009824A2 BR PI1009824 A2 BRPI1009824 A2 BR PI1009824A2 BR PI1009824 A BRPI1009824 A BR PI1009824A BR PI1009824 A BRPI1009824 A BR PI1009824A BR PI1009824 A2 BRPI1009824 A2 BR PI1009824A2
- Authority
- BR
- Brazil
- Prior art keywords
- solid
- dosage form
- dispersion
- solid dosage
- solid dispersion
- Prior art date
Links
- 239000007962 solid dispersion Substances 0.000 title 1
- 239000007909 solid dosage form Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Physiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15856609P | 2009-03-09 | 2009-03-09 | |
| US61/158,566 | 2009-03-09 | ||
| US12/661,016 US8617588B2 (en) | 2009-03-09 | 2010-03-09 | Highly compactable and durable direct compression excipients and excipient systems |
| PCT/US2010/000701 WO2010104563A2 (en) | 2009-03-09 | 2010-03-09 | Highly compactable and durable direct compression excipients and excipient systems |
| US12/661,016 | 2010-03-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI1009824A2 true BRPI1009824A2 (pt) | 2016-03-15 |
| BRPI1009824B1 BRPI1009824B1 (pt) | 2020-02-18 |
Family
ID=42646287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1009824-0A BRPI1009824B1 (pt) | 2009-03-09 | 2010-03-09 | Forma de farmacêutica sólida compreendendo uma dispersão altamente compactável e durável incluindo carboidratos co-processados |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US8617588B2 (pt) |
| EP (1) | EP2405905B1 (pt) |
| JP (2) | JP5806124B2 (pt) |
| KR (1) | KR101817361B1 (pt) |
| AU (1) | AU2010223105B2 (pt) |
| BR (1) | BRPI1009824B1 (pt) |
| CA (1) | CA2753685C (pt) |
| ES (1) | ES2588429T3 (pt) |
| MX (1) | MX2011009053A (pt) |
| WO (1) | WO2010104563A2 (pt) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL169678A (en) | 2005-07-14 | 2010-11-30 | Innova Sa | Sweetener compositions |
| US8617588B2 (en) | 2009-03-09 | 2013-12-31 | Spi Pharma, Inc. | Highly compactable and durable direct compression excipients and excipient systems |
| US8354593B2 (en) * | 2009-07-10 | 2013-01-15 | Nanocomp Technologies, Inc. | Hybrid conductors and method of making same |
| MX364560B (es) | 2010-09-20 | 2019-05-02 | Spi Pharma Inc Star | Proceso de microencapsulacion y producto. |
| EP2841057B1 (en) | 2012-04-25 | 2019-03-20 | SPI Pharma, INC. | Crystalline microspheres and the process for manufacturing the same |
| WO2013171164A1 (en) | 2012-05-14 | 2013-11-21 | EJP Pharmaceutical ApS | Compositions and formulations for the treatment of halitosis |
| CN103783512B (zh) * | 2013-12-31 | 2016-08-17 | 陈慧婷 | 一种桂圆大枣山药分散片及制备方法 |
| CN103704558B (zh) * | 2013-12-31 | 2015-12-02 | 陈慧婷 | 一种防风大枣分散片及制备方法 |
| US10207004B2 (en) | 2014-04-04 | 2019-02-19 | Douxmatok Ltd | Method for producing sweetener compositions and sweetener compositions |
| US20160242439A1 (en) | 2014-04-04 | 2016-08-25 | Douxmatok Ltd | Method for producing sweetener compositions and sweetener compositions |
| US10231476B2 (en) | 2014-04-04 | 2019-03-19 | Douxmatok Ltd | Sweetener compositions and foods, beverages, and consumable products made thereof |
| FR3023177B1 (fr) * | 2014-07-04 | 2016-08-12 | Centre Nat De La Rech Scient (C N R S) | Procede de preparation de co-cristaux par evaporation flash |
| JP6718866B2 (ja) * | 2014-10-16 | 2020-07-08 | カーギル インコーポレイテッド | 直接圧縮性のエリスリトールの調製方法及びその使用 |
| US10632076B2 (en) | 2016-11-18 | 2020-04-28 | Fertin Pharma A/S | Tablet comprising separate binder and erythritol |
| US10543205B2 (en) | 2016-11-18 | 2020-01-28 | Fertin Pharma A/S | Oral delivery vehicle containing nicotine |
| US11096894B2 (en) | 2018-05-17 | 2021-08-24 | Fertin Pharma A/S | Oral tablet for induced saliva generation |
| US11096896B2 (en) | 2018-05-17 | 2021-08-24 | Fertin Pharma A/S | Tablet dosage form for buccal absorption of active ingredients |
| US11052047B2 (en) | 2018-05-17 | 2021-07-06 | Fertin Pharma A/S | Oral tablet suitable for fast release of active pharmaceutical ingredients |
| US11058633B2 (en) | 2018-05-17 | 2021-07-13 | Fertin Pharma A/S | Disintegrating oral tablet suitable for active pharmaceutical ingredients |
| US11058641B2 (en) | 2018-05-17 | 2021-07-13 | Fertin Pharma A/S | Oral tablet for taste masking of active ingredients |
| US11090263B2 (en) | 2018-05-22 | 2021-08-17 | Fertin Pharma A/S | Tableted chewing gum suitable for active pharmaceutical ingredients |
| US11096895B2 (en) * | 2018-05-17 | 2021-08-24 | Fertin Pharma A/S | Oral tablet suitable for active pharmaceutical ingredients |
| US11135157B2 (en) * | 2018-05-17 | 2021-10-05 | Fertin Pharma A/S | Oral tablet for delivery of active ingredients to the throat |
| US20190350858A1 (en) | 2018-05-17 | 2019-11-21 | Fertin Pharma A/S | Oral tablet for delivery of active ingredients to the gastrointestinal tract |
| CA3181782A1 (en) | 2020-05-09 | 2021-11-18 | Arvinas Operations, Inc. | Methods of manufacturing a bifunctional compound, ultrapure forms of the bifunctional compound, and dosage forms comprising the same |
| BR112022022918A2 (pt) * | 2020-05-15 | 2023-01-31 | Spi Pharma Inc | Sistema de excipiente, forma de dosagem feita a partir do sistema de excipiente, compacto do sistema de excipiente, forma de dosagem sólida e método para endurecimento pós-compressão |
| US20230099344A1 (en) | 2021-06-15 | 2023-03-30 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of irak-4 |
| TW202500155A (zh) | 2023-06-12 | 2025-01-01 | 美商亞文納營運公司 | 雌激素受體降解劑之固體口服劑型 |
| WO2025226973A1 (en) | 2024-04-25 | 2025-10-30 | Arvinas Operations, Inc. | Pharmaceutical formulations of an androgen receptor-targeting protein degrader |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3245170A1 (de) | 1982-12-07 | 1984-06-07 | Merck Patent Gmbh, 6100 Darmstadt | Verbesserter sorbit, verfahren zur herstellung und verwendung |
| EP0272265B1 (de) | 1985-09-25 | 1991-05-22 | Gergely, Gerhard, Dr. | Zerfallstablette und verfahren zu ihrer herstellung |
| US4990537A (en) | 1988-07-11 | 1991-02-05 | Banyu Pharmaceutical Co., Ltd. | Anti influenza agent |
| FI894611A7 (fi) | 1988-09-30 | 1990-03-31 | May & Baker Ltd | Rakeisia farmaseuttisia valmisteita |
| US5583215A (en) | 1990-06-25 | 1996-12-10 | Towa Chemical Industry Co., Ltd. | Crystalline mixture solid containing maltitol and a process for preparing it |
| IE67345B1 (en) | 1991-03-12 | 1996-03-20 | Akzo Nv | Low dose dry pharmaceutical preparations |
| US5464632C1 (en) | 1991-07-22 | 2001-02-20 | Prographarm Lab | Rapidly disintegratable multiparticular tablet |
| DE69331839T2 (de) | 1992-01-29 | 2002-12-12 | Takeda Chemical Industries, Ltd. | Schnellösliche Tablette und ihre Herstellung |
| US5576014A (en) | 1994-01-31 | 1996-11-19 | Yamanouchi Pharmaceutical Co., Ltd | Intrabuccally dissolving compressed moldings and production process thereof |
| US5635210A (en) | 1994-02-03 | 1997-06-03 | The Board Of Regents Of The University Of Oklahoma | Method of making a rapidly dissolving tablet |
| DE4439858A1 (de) | 1994-11-08 | 1996-05-09 | Merck Patent Gmbh | Durch Co-Sprühtrocknung erhältliche Polyol-Zusammensetzung |
| DE19615418A1 (de) | 1996-04-22 | 1997-10-23 | Merck Patent Gmbh | Polyol-Zusammensetzung |
| DE19617487A1 (de) | 1996-05-02 | 1997-11-06 | Merck Patent Gmbh | Geschmacksverbesserung von Arzneimittelwirkstoffen |
| EP0839526A3 (en) | 1996-10-31 | 1999-01-07 | Takeda Chemical Industries, Ltd. | Solid pharmaceutical preparation with fast buccal disintegration or dissolution |
| DE59711923D1 (de) * | 1996-11-15 | 2004-10-21 | Merck Patent Gmbh | Verfahren zur herstellung von geformten oder ungeformten polyolmassen und hergestelle zusammensetzungen |
| JPH10257009A (ja) * | 1997-03-10 | 1998-09-25 | Oki Electric Ind Co Ltd | 無線中継方法及び無線中継機 |
| US6024981A (en) | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
| SK146699A3 (en) | 1997-05-01 | 2000-05-16 | Nissan Chemical Ind Ltd | Benzimidazole derivative |
| FR2766089B1 (fr) | 1997-07-21 | 2000-06-02 | Prographarm Lab | Comprime multiparticulaire perfectionne a delitement rapide |
| JP2001519378A (ja) | 1997-10-15 | 2001-10-23 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | 直接圧縮可能な錠剤化助剤の製造 |
| DE19820957A1 (de) | 1998-05-11 | 1999-11-25 | Merck Patent Gmbh | Verfahren zur Herstellung von Mannit |
| GT199900061A (es) | 1998-05-15 | 2000-10-14 | Pfizer | Formulaciones farmaceuticas. |
| FR2781152B1 (fr) * | 1998-07-20 | 2001-07-06 | Permatec Tech Ag | Utilisation d'un polymere de type acrylique en tant qu'agent de desagregation |
| US20040127470A1 (en) * | 1998-12-23 | 2004-07-01 | Pharmacia Corporation | Methods and compositions for the prevention or treatment of neoplasia comprising a Cox-2 inhibitor in combination with an epidermal growth factor receptor antagonist |
| ES2242598T3 (es) | 1999-02-17 | 2005-11-16 | Kyowa Hakko Kogyo Co., Ltd. | Comprimidos y procedimiento para producir comprimidos. |
| US20020071864A1 (en) | 1999-03-25 | 2002-06-13 | Yuhan Corporation | Rapidly disintegrable tablet for oral administration |
| DE19927537A1 (de) | 1999-06-16 | 2000-12-21 | Merck Patent Gmbh | Sprühtrocknungsanlage und Verfahren zu ihrer Verwendung |
| CA2374760A1 (en) | 1999-06-18 | 2000-12-28 | Takeda Chemical Industries, Ltd. | Quickly disintegrating solid preparations |
| US6284270B1 (en) | 1999-08-04 | 2001-09-04 | Drugtech Corporation | Means for creating a mass having structural integrity |
| FR2798289B1 (fr) | 1999-09-15 | 2004-12-31 | Cll Pharma | Formes galeniques a delitement rapide en bouche et leur procede de preparation |
| US6248359B1 (en) | 2000-01-05 | 2001-06-19 | Laboratorios Phoenix U.S.A., Inc. | Multi-tablet oxybutynin system for treating incontinence |
| US20030188679A1 (en) | 2000-08-25 | 2003-10-09 | Eugen Schwarz | Powdered mannitol and mannitol-containing compositions |
| US6814978B2 (en) | 2000-12-29 | 2004-11-09 | Mcneil-Ppc, Inc. | Process for preparing a soft tablet |
| AU2002238848B2 (en) | 2001-03-06 | 2007-11-15 | Kyowa Hakko Kogyo Co., Ltd. | Use of a spray-dried powder comprising a sugar alcohol |
| CA2440361A1 (en) | 2001-03-06 | 2002-09-12 | Kyowa Hakko Kogyo Co. Ltd. | Intraorally rapidly disintegrable preparation |
| US6872405B2 (en) | 2001-05-10 | 2005-03-29 | Yamanouchi Pharmaceutical Co., Ltd. | Quick-disintegrating tablet in buccal cavity and manufacturing method thereof |
| FR2831820B1 (fr) | 2001-11-05 | 2004-08-20 | Ethypharm Sa | Comprime orodispersible presentant une grande homogeneite et son procede de preparation |
| US7118765B2 (en) * | 2001-12-17 | 2006-10-10 | Spi Pharma, Inc. | Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms |
| US7282217B1 (en) | 2003-08-29 | 2007-10-16 | Kv Pharmaceutical Company | Rapidly disintegrable tablets |
| JP3841804B2 (ja) | 2003-10-15 | 2006-11-08 | 富士化学工業株式会社 | 口腔内速崩壊性錠剤用の組成物 |
| WO2005037254A1 (ja) * | 2003-10-15 | 2005-04-28 | Fuji Chemical Industry Co., Ltd. | 口腔内速崩壊性錠剤 |
| US20070092562A1 (en) * | 2003-10-28 | 2007-04-26 | Spi Pharma, Inc. | Product and process for increasing compactibility of carbohydrates |
| EP1965761B1 (de) | 2005-12-21 | 2015-07-01 | Basf Se | Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten |
| US8962022B2 (en) * | 2007-03-27 | 2015-02-24 | Aptalis Pharmatech, Inc. | Pharmaceutical compositions comprising an active substance from the substituted benzhydrylpiperazine family |
| US8617588B2 (en) | 2009-03-09 | 2013-12-31 | Spi Pharma, Inc. | Highly compactable and durable direct compression excipients and excipient systems |
-
2010
- 2010-03-09 US US12/661,016 patent/US8617588B2/en active Active
- 2010-03-09 CA CA2753685A patent/CA2753685C/en active Active
- 2010-03-09 ES ES10742920.1T patent/ES2588429T3/es active Active
- 2010-03-09 WO PCT/US2010/000701 patent/WO2010104563A2/en not_active Ceased
- 2010-03-09 EP EP10742920.1A patent/EP2405905B1/en active Active
- 2010-03-09 KR KR1020117019869A patent/KR101817361B1/ko active Active
- 2010-03-09 MX MX2011009053A patent/MX2011009053A/es active IP Right Grant
- 2010-03-09 BR BRPI1009824-0A patent/BRPI1009824B1/pt active IP Right Grant
- 2010-03-09 AU AU2010223105A patent/AU2010223105B2/en active Active
- 2010-03-09 JP JP2011554038A patent/JP5806124B2/ja active Active
-
2013
- 2013-12-05 US US14/097,773 patent/US9358212B2/en active Active
-
2015
- 2015-09-03 JP JP2015173680A patent/JP6104334B2/ja active Active
-
2016
- 2016-05-25 US US15/163,776 patent/US11672763B2/en active Active
-
2023
- 2023-04-28 US US18/309,066 patent/US20230255891A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20160263036A1 (en) | 2016-09-15 |
| AU2010223105A1 (en) | 2011-09-08 |
| US9358212B2 (en) | 2016-06-07 |
| BRPI1009824B1 (pt) | 2020-02-18 |
| CA2753685C (en) | 2017-09-12 |
| US20140093574A1 (en) | 2014-04-03 |
| US11672763B2 (en) | 2023-06-13 |
| WO2010104563A2 (en) | 2010-09-16 |
| US20100226964A1 (en) | 2010-09-09 |
| JP6104334B2 (ja) | 2017-03-29 |
| JP2012519729A (ja) | 2012-08-30 |
| JP5806124B2 (ja) | 2015-11-10 |
| AU2010223105B2 (en) | 2016-05-12 |
| JP2016041692A (ja) | 2016-03-31 |
| US8617588B2 (en) | 2013-12-31 |
| US20230255891A1 (en) | 2023-08-17 |
| KR101817361B1 (ko) | 2018-01-11 |
| CA2753685A1 (en) | 2010-09-16 |
| MX2011009053A (es) | 2012-04-02 |
| EP2405905B1 (en) | 2016-06-29 |
| KR20110128829A (ko) | 2011-11-30 |
| ES2588429T3 (es) | 2016-11-02 |
| WO2010104563A3 (en) | 2011-08-11 |
| EP2405905A2 (en) | 2012-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1009824A2 (pt) | dispersão sólida e forma farmacêutica sólida. | |
| BRPI1008023A2 (pt) | forma de dosagem sólida | |
| BRPI1008683A2 (pt) | montagem de prevenção e queda. | |
| BRPI1012883A2 (pt) | dispositivo intercorporal. | |
| HRP20160737T1 (hr) | Anti-her3-protutijela i njihove uporabe | |
| BR112013014361A2 (pt) | forma de dosagem | |
| EP2281635A4 (en) | CUTTER | |
| BRPI1016117A8 (pt) | derivados de isoxazol-isoxazol e isoxazol-isotiazol. | |
| DK2417204T3 (da) | Piezokromt sikkerhedselement | |
| FR2947376B1 (fr) | Sectionneur. | |
| BRPI1009811A2 (pt) | transmissão. | |
| BRPI0925077A2 (pt) | Conjunto dispensador. | |
| BR112013002544A2 (pt) | seção de armario e armario | |
| IT1396487B1 (it) | Convogliatore. | |
| BRPI1014641A2 (pt) | arilpirrolidinas pesticidas | |
| ITMI20110483A1 (it) | Durometro. | |
| BR112012002612A2 (pt) | calha. | |
| BRPI0921487A2 (pt) | triturador cônico | |
| FR2942385B1 (fr) | Grille-pain. | |
| ES1070429Y (es) | Traspaleta mejorada | |
| BR112012003860A2 (pt) | Combinação, e, composição nutricional | |
| BRPI1008675A2 (pt) | grânulos. | |
| ES1071902Y (es) | Mecanismo de termosoldadura y precorte | |
| EP2485753A4 (en) | VARIANTS OF THE CHAPERONINE IN POSITION 10 | |
| IT1394461B1 (it) | Dispositivo spollonatore. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 3A ANUIDADE. |
|
| B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/03/2010, OBSERVADAS AS CONDICOES LEGAIS. |